Traders should watch for potential downward pressure on KALV shares; consider this insider monetization a cautionary signal ahead of next earnings or clinical updates. Monitor for Form 4 filings indicating further sales or any offsetting buying.
Price Chart
Executive Summary
Multiple C-suite executives at KalVista Pharmaceuticals (KALV) sold shares in a coordinated cluster over the past week, including the CEO, CFO, CMO, CDO, and CCO, realizing nearly $400K in total proceeds. The sales coincide with recent market activity showing insider selling pressure, raising concerns about near-term prospects despite no disclosed material events.
Key Financial Metrics
Key Facts
- CEO Palleiko sold $156,197 worth of shares, the largest individual sale in the cluster.
- All five C-suite executives participated in sales, totaling $396,600 in realized value.
- Concurrent with share sales, insiders also exercised stock options (marketed transactions, 'M') for 49,500 shares at $0 cost, indicating option monetization.
- No insider buying was observed — all activity was selling or option exercise.
- Recent 30-day insider activity shows continued selling pressure totaling $397K, consistent with this cluster.
Financial Impact
$396,600 in insider sales over 7 days, all from senior executives
Risk Factors
- Insider selling may signal lack of confidence in near-term catalysts or valuation.
- Market could interpret coordinated C-suite exits as negative, especially if no public explanation is provided.
- Exercised options may lead to incremental share dilution or sustained selling pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (13 trades, 7d window) | cluster-KALV-1771980287247 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 22, 2026 14w ago | 15-12G | — | awaiting T+1 | — | — |
Jun 17, 2026 15w ago | EFFECT | $27.00 awaiting T+1 | awaiting T+1 | — | — |
Jun 11, 2026 16w ago | 8-K | $26.99 awaiting T+1 | awaiting T+1 | — | — |
Jun 11, 2026 16w ago | Institutional Cluster | $27.00 $27.00 | · 0.00% | ▼ −0.54% | — |
May 19, 2026 19w ago | Insider Cluster | $26.81 $26.77 | ▲ +0.15% | ▲ +0.34% | — |
May 19, 2026 19w ago | Insider Cluster | $26.81 $26.77 | ▼ −0.15% | ▼ −0.34% | — |
Apr 29, 2026 22w ago | 8-K | $26.67 $26.66 | ▼ −0.04% | ▼ −1.06% | — |
Apr 17, 2026 24w ago | Insider Cluster | $20.48 $20.87 | ▼ −1.90% | ▼ −2.10% | — |
Feb 23, 2026 31w ago | Insider Cluster | $15.56 $15.77 | ▼ −1.35% | ▼ −0.61% | — |
Feb 23, 2026 31w ago | Insider Cluster | $15.56 $15.77 | ▼ −1.35% | ▼ −0.61% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access